[go: up one dir, main page]

AU2001294376A1 - Dextran hydrogels - Google Patents

Dextran hydrogels

Info

Publication number
AU2001294376A1
AU2001294376A1 AU2001294376A AU9437601A AU2001294376A1 AU 2001294376 A1 AU2001294376 A1 AU 2001294376A1 AU 2001294376 A AU2001294376 A AU 2001294376A AU 9437601 A AU9437601 A AU 9437601A AU 2001294376 A1 AU2001294376 A1 AU 2001294376A1
Authority
AU
Australia
Prior art keywords
dextran hydrogels
hydrogels
dextran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294376A
Inventor
Wilhelmus Everhardus Hennink
Robert Jacob Herman Stenekes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octoplus BV
Original Assignee
Octoplus BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octoplus BV filed Critical Octoplus BV
Publication of AU2001294376A1 publication Critical patent/AU2001294376A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/02—Dextran; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2001294376A 2000-08-31 2001-08-30 Dextran hydrogels Abandoned AU2001294376A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203030 2000-08-31
EP00203030A EP1184032A1 (en) 2000-08-31 2000-08-31 Dextran hydrogels
PCT/NL2001/000640 WO2002017884A1 (en) 2000-08-31 2001-08-30 Dextran hydrogels

Publications (1)

Publication Number Publication Date
AU2001294376A1 true AU2001294376A1 (en) 2002-03-13

Family

ID=8171969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294376A Abandoned AU2001294376A1 (en) 2000-08-31 2001-08-30 Dextran hydrogels

Country Status (3)

Country Link
EP (1) EP1184032A1 (en)
AU (1) AU2001294376A1 (en)
WO (1) WO2002017884A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200508021B (en) * 2003-03-04 2007-03-28 Technology Dev Company Ltd Delivery system for drug and cell therapy
MXPA05009493A (en) * 2003-03-04 2006-08-11 Ttdc Bio L P Oral insulin composition and methods of making and using thereof.
DE10358387A1 (en) * 2003-12-13 2005-07-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder containing low molecular weight dextran and process for their preparation
TW200603843A (en) * 2004-04-20 2006-02-01 Technology Dev Company Ltd Tissue enhancement implant and method
EP1595534A1 (en) 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gel composition comprising charged polymers
JP5401095B2 (en) 2005-11-17 2014-01-29 ゾゲニクス インコーポレーティッド Delivery method of viscous preparation by needle-free injection
SE0600091L (en) 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Process for the preparation of a dextran matrix for controlled release of insulin
CA2722743A1 (en) 2008-04-28 2009-11-05 Zogenix, Inc. Novel formulations for treatment of migraine
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
EP2305717A1 (en) 2009-09-21 2011-04-06 Koninklijke Nederlandse Akademie van Wetenschappen Inhibiting TNIK for treating colon cancer
EP2575498A1 (en) 2010-05-04 2013-04-10 Cargill, Incorporated Fat replacers and filling materials
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
RU2455007C1 (en) * 2010-11-01 2012-07-10 Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" Method for producing gel-forming dextrane phosphates
EP2465928A1 (en) 2010-12-16 2012-06-20 Academisch Medisch Centrum bij de Universiteit van Amsterdam Treatment of Th17-mediated diseases
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
CN112646052A (en) * 2020-12-22 2021-04-13 南京工业大学 High-crystallinity water-insoluble dextran, and preparation and application thereof
CN117281260A (en) * 2023-11-24 2023-12-26 上海威高医疗技术发展有限公司 Gel without cross-linking agent and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336546C2 (en) * 1972-07-21 1984-09-20 Pharmacia AB, Uppsala Diagnostic agent suitable for introduction into body cavities
SE8204244L (en) * 1982-07-09 1984-01-10 Ulf Schroder Crystallized Carbohydrate Matrix for BIOLOGICALLY ACTIVE SUBSTANCES

Also Published As

Publication number Publication date
EP1184032A1 (en) 2002-03-06
WO2002017884A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002258913A1 (en) Bifunctional-modified hydrogels
AU6419701A (en) Electropancreatography
AU2000267458A1 (en) Hypercomputer
AU2371601A (en) Hydrogels
AU2002258490A1 (en) Polysaccharide-based polmerizable hydrogels
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001294376A1 (en) Dextran hydrogels
AU4977800A (en) (in situ) forming hydrogels
AU2001284222A1 (en) Pivot bearing
AUPR381201A0 (en) Improved pivot assemblies
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU7431901A (en) Coherence-free cache
AU2001293852A1 (en) Sulfonylguanidine
AU2001269090A1 (en) Double half-carcass tyre
AU5276401A (en) Vehicle
AU7634800A (en) Scissors
AU2001267941A1 (en) Sailcraft
AUPR345701A0 (en) Pivot means
AU2001100129A4 (en) Easy-loader trailer
AU785203C (en) Zeroclick
AUPR192300A0 (en) Camper
AUPQ701100A0 (en) Vehicle
AUPQ601200A0 (en) Vehicle
AUPR319901A0 (en) Improved caravan